Monitor for follow-up filings to determine if the CEO's purchase signals confidence amid broader insider selling. Consider the divergence between executive and other insider behavior as a potential sentiment signal.
IMNM drugs
IMNM drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 23 $20.75entry
- T+1 · 8mo ago −2.60%α −2.25% · $20.21
- T+5 · 8mo ago −6.99%α −3.42% · $19.30
- T+20 · 7mo ago +12.14%α +4.72% · $23.27
- T+60 · 5mo ago −10.70%α −23.76% · $18.53
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable. Recent insider activity shows CEO Clay Siegall purchased $500,601.5 worth of shares in an open-market transaction, contrasting with prior selling activity by other insiders.
Key Financial Metrics
Key Facts
- Filing is an insider trading cluster (CLUSTER) for Immunome Inc. (IMNM).
- Document content unavailable; analysis based on metadata and cross-filing context.
- CEO Clay Siegall purchased $500,601.5 in shares over the past 7 days.
- Other insiders sold $1.3M in shares over the past 30 days, while total buys amounted to $544K.
Financial Impact
$500,601.5 purchase by CEO, offset by $1.3M in recent insider sales
Risk Factors
- Limited visibility due to unavailable filing content.
- Mixed signals from insider activity: CEO buying while others have been net sellers.
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
20 reports on IMNM
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +26.53% at T+60 after the May 28, 2026 report. 6 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $18.39 Now $17.61 −4.24% settles Feb 12
- Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
- Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $18.65 Now $17.61 +5.58% settles Feb 8
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $18.21 Now $17.61 −3.29% settles Jan 28
- Oct 16, 20264w ago ANALYST-UPGRADE Bullish 4/10 Entry $16.47 Now $17.61 +6.92% settles Jan 13
- Oct 5, 20266w ago 8-K Bullish 6/10 Entry $21.17 Now $17.61 −16.82% settles Dec 30
- Oct 1, 20266w ago ANALYST-UPGRADE Bearish 4/10 Entry $20.89 Now $17.61 +15.70% settles Dec 28
- Sep 21, 20268w ago ANALYST-UPGRADE Bullish 4/10 Entry $25.07 Now $17.61 −29.76% settles Dec 15
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $26.42 to $18.71 Now $17.61 −33.35% ▼ −29.18% −23.71% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers